1. Home
  2. HSCS

Stocks

Health Care

Medical Specialities

Nasdaq

HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.

Founded: 2007 Country:
United States
United States
Employees: N/A City: SOUTHLAKE
Market Cap: 9.9M IPO Year: 2022
Target Price: $10.50 AVG Volume (30 days): 94.3K
Analyst Decision: Strong Buy Number of Analysts: 2
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -8.20 EPS Growth: N/A
52 Week Low/High: $2.52 - $6.47 Next Earning Date: 09-11-2025
Revenue: $6,250 Revenue Growth: -66.40%
Revenue Growth (this year): 13968.97% Revenue Growth (next year): 166.67%

Share on Social Networks: